Blog Posts
Sandip Patel
Sandip Patel/stemcells.ucsd.edu

Sandip Patel Highlights the Role of Full Genomic Profiling in Stage IV NSCLC – DAVA Oncology

DAVA Oncology shared a post on X:

“Dr. Sandip Patel at DAVA Lung highlights the role of full genomic profiling in Stage IV NSCLC. For EGFR mutations: osimertinib, chemo-osimertinib, or amivantamab+lazertinib. Future strategies may hinge on molecular risk and balancing patient burden.”

Sandip Patel Highlights the Role of Full Genomic Profiling in Stage IV NSCLC - DAVA Oncology

More posts featuring DAVA Oncology.

cancer DAVA Lung DAVA Oncology NSCLC OncoDaily Oncology Sandip Patel